MCL1 and neoplasm: Similarly, loss of a single Mcl-1 allele also delayed tumor onset and impaired the survival of T-cell lymphomas developed in a T lymphocyte non-Hodgkin’s lymphoma (T-NHL) mouse model driven by the fusion kinase ITK-SYK signaling.